$CGTX

$0.76 +$0.06 (9.24%) Close

$CGTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 95.1M shares outstanding

Who owns CGTX?

By type of holder

Institutions 23.8% Insiders 28.4% Everyone else 47.8%

Concentration Top 10 holders own 49.5%

Aaron G.L. Fletcher 6.4% · Bios Advisors GP, LLC 6.3%

Institutional ownership

23.8%

+1.2 pts vs last qtr

Institutional holders

-9 vs last qtr

Net shares bought

+1.2M

by institutions in Q2 2026

New / sold out

4 / 13

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

DAVENPORT & Co LLC +1.4M
Vanguard Capital Management LLC +437.0K

Biggest sellers in Q2 2026

Renaissance Technologies LLC −423.8K
Jane Street Group, LLC SOLD OUT −370.1K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Cognition Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+14221.1%

+169.90% a year

Each share's claim on the business

−99.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $19.4M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years31% 1–3 years40% Under 1 year29%

Quarterly turnover

9.5%

of institutional shares changed hands

Top 10 managers, median time held

2.5 years

Super Investors

Investment managers reporting CGTX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
BC BIOS Capital Management, LP 13D · 6.8%	6.0M	6.31%	Unchanged	2024	16.6%
Shares held by quarter Peak holding6.0M (Q4'24) Change over 8 quarters+6.0M Share of the company6.310% Disclosed stake13D · 6.8% BIOS Capital Management, LP's full portfolio →
D DAVENPORT & Co LLC	4.3M	4.48%	+1.4M (+47.2%)	Q3 '25	0.0%
Shares held by quarter Peak holding4.3M (Q2'26) Change over 8 quarters+4.3M Share of the company4.480% DAVENPORT & Co LLC's full portfolio →

BIOS Capital Management, LP

13D · 6.8%

6.0M

% of company

6.31%

Change vs last qtr

Unchanged

Held since

2024

DAVENPORT & Co LLC

4.3M

% of company

4.48%

Change vs last qtr

+1.4M (+47.2%)

Held since

Q3 '25

28 more super investors behind a free account

See every manager holding Cognition Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CGTX on Form N-PORT; together they hold 4.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$2.81M	2.4M	2.57%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$1M	871.6K	0.92%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$2.81M

% of company

2.57%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$1M

% of company

0.92%

% of the fund

0.00%

As of

June 30, 2026

14 more funds behind a free account

See every fund holding Cognition Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AG Aaron G.L. Fletcher 5%+ holder 13D · 6.9%	6.1M	6.37%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company6.370% Disclosed stake13D · 6.9% View the 13D/G filing →
BA Bios Advisors GP, LLC 5%+ holder 13D · 6.8%	6.0M	6.34%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company6.340% Disclosed stake13D · 6.8% View the 13D/G filing →

Aaron G.L. Fletcher

5%+ holder13D · 6.9%

6.1M

% of company

6.37%

Change vs last qtr

—

Held since

—

Bios Advisors GP, LLC

5%+ holder13D · 6.8%

6.0M

% of company

6.34%

Change vs last qtr

—

Held since

—

26 more holders behind a free account

See every insider and 5%+ holder of Cognition Therapeutics Inc.

Comments